STOCK TITAN

AEHR (AEHR) EVP Salamone sells 30,000 shares, retains 48,025-share stake

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

AEHR TEST SYSTEMS EVP Alberto Salamone reported two open-market sales of common stock. He sold 15,000 shares at $94.56 on April 21, 2026 and 15,000 shares at $89.57 on April 20, 2026, totaling 30,000 shares sold.

After these sales, he directly holds 48,025 shares of AEHR common stock. A footnote states this amount includes shares subject to unvested restricted stock units, meaning part of his reported holdings are still vesting over time.

Positive

  • None.

Negative

  • None.

Insights

EVP executed two routine open-market sales and retains a sizable equity stake.

EVP, PPBI Business Alberto Salamone sold a combined 30,000 shares of AEHR TEST SYSTEMS common stock in two open-market transactions at prices of $89.57 and $94.56 per share. These are straightforward sale transactions, not option exercises or gifts.

Following the sales, he directly holds 48,025 shares, and a footnote clarifies this figure includes unvested restricted stock units. With no derivative positions reported and no reference to pre-arranged trading plans, the filing mainly shows portfolio rebalancing while maintaining ongoing equity exposure.

Insider SALAMONE ALBERTO
Role EVP, PPBI BUSINESS
Sold 30,000 shs ($2.76M)
Type Security Shares Price Value
Sale Common Stock 15,000 $94.56 $1.42M
Sale Common Stock 15,000 $89.57 $1.34M
Holdings After Transaction: Common Stock — 48,025 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold April 20, 2026 15,000 shares at $89.57 Open-market sale of AEHR common stock
Shares sold April 21, 2026 15,000 shares at $94.56 Open-market sale of AEHR common stock
Total shares sold 30,000 shares Combined open-market sales reported on Form 4
Shares held after transactions 48,025 shares Direct holdings after sales, includes unvested RSUs
Net buy/sell direction -30,000 shares Net-sell across reported transactions
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
restricted stock units financial
"includes shares subject to unvested restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
non-derivative financial
"transaction_type": "non-derivative""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SALAMONE ALBERTO

(Last)(First)(Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, PPBI BUSINESS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/20/2026S15,000D$89.5763,025D
Common Stock04/21/2026S15,000D$94.5648,025(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact04/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did AEHR EVP Alberto Salamone report on this Form 4?

Alberto Salamone reported two open-market sales of AEHR common stock, selling 15,000 shares at $89.57 and another 15,000 shares at $94.56. These transactions total 30,000 shares sold over two consecutive days.

At what prices did AEHR EVP Alberto Salamone sell his shares?

He sold 15,000 shares at $89.57 per share on April 20, 2026, and another 15,000 shares at $94.56 per share on April 21, 2026. Both transactions are classified as open-market sales of common stock.

How many AEHR shares does Alberto Salamone hold after these sales?

After the reported sales, Alberto Salamone directly holds 48,025 shares of AEHR common stock. A footnote explains that this amount includes shares subject to unvested restricted stock units, meaning part of his position is still vesting over time.

Were any derivatives or stock options involved in Alberto Salamone’s AEHR transactions?

No, the filing only shows non-derivative transactions in AEHR common stock, both coded as open-market sales. The derivativeSummary section is empty, indicating no reported option exercises, warrant conversions, or other derivative activities in this specific Form 4.

Does the AEHR Form 4 indicate if Alberto Salamone’s sales were pre-planned?

The provided Form 4 data does not reference any Rule 10b5-1 trading plan or pre-arranged program. The transactions are simply described as sales in open market or private transactions, without additional planning or scheduling details in the available excerpt.